APX2039
APX2039 is an orally active fungal Gwt1 enzyme inhibitor and a prodrug of the novel Gwt2096 inhibitor APX1.APX2039 exhibits potent anti-Kryptococcal activity against C. neoformans and C. gattii.APX2039 exhibits potent antifungal activity and blocks the localization of GPI (glycosylphosphatidylinositol) anchored cell wall mannoproteins. APX2039 has potent antifungal activity and blocks the localization of GPI (glycosylphosphatidylinositol) -anchored cell wall mannoproteins.APX2039 can be used to study cryptococcal meningitis (CM) .
Product Specifications
CAS Number
2342606-49-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
362.36
Molecular Formula
C20H15FN4O2
Notes
Research use only, not for human use.
Receptor
Antifungal
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog